semaglutide and ovarian cancer Everyone is talking about Ozempic Wegovy for weight loss. But as a gynecologic oncologist what has my attention is what these medications may be doing to risk. Here is what Semaglutide and metformin improve menstrual

Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK

Semaglutide, sold under the brand names Wegovy, Ozempic and Rybelsus, has been hailed as a potential game changer in tackling obesity, but can also significantly improve blood sugar control and weight loss in diabetics for up to three years, researchers said

That means right in the environment surrounding where most lesions are found

Impact on Laboratory Test Results When individuals receive methylcobalamin injections, changes in laboratory test outcomes such as serum B12 levels and homocysteine measurements may occur, which can impact the understanding of test results and possibly result in misdiagnosis or improper treatment adjustments by healthcare professionals analyzing lab work of patients undergoing methylcobalamin therapy

New research in @NatureCVR about patients enrolled in a randomized, double-blind trial about myocardial inflammation after a heart attack

Safety and Metabolism of Long-term Administration of NIAGEN in Healthy Overweight Adults